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DIAGNOSING
BREAST CANCER
WITH PET
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IVlore than 400 cancer survivors,
family, friends, and caregivers gathered in The Eric P. Newman Education
Center on the Washington University
Medical Center campus to celebrate
life and to share the memories of
hard-fought battles and sweet
victories over a dreaded disease. ▼

1 Herman Bockstruck, 22-year cancer survivor;
Carlos Perez, MD, director of the Radiation
Oncology Center; and William Peck, MD, dean
of the medical school.
2 Washington University Chancellor Mark
Wrighton visited with former patients and
their guests.
3 Code Blues provided swinging sounds and a
feel-good mood.
4 Radiation Oncology's Perry Cole and Ernestine Easley welcomed Virgil and Lillian Petty.
5 Dr. Carlos and Susie Perez with Chester
Moore (third from left), his family and friends.
6 Dr. Todd Wasserman, who has been
organizing Celebration of Life since 1989, and
ten-year-old Adam Gacioch, the youngest cancer
survivor attending the event.
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AN ATLAS OF DISCOVERY
Researchers in MIR's molecular radiopharmacology lab
are investigating why some tumor cells reject certain
chemotherapeutic agents. Information gained from this
study could result in improved treatment for patients
with cancer.

14 PET: A

LOGICAL TOOL
IN THE FIGHT AGAINST
BREAST CANCER

Two significant clinical trials will determine if
positron emission tomography (PET) is an effective,
noninvasive method for evaluating lymph-node
involvement in breast cancer and for identifying
which estrogen-receptor-positive breast tumors will
respond to hormonal therapy.

IN MEMORIAM
A tribute to Dr. Michel Ter-Pogossian, an innovative
researcher known as "the father of PET," who devoted
more than four decades to the improvement of medical
imaging.
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ON THE COVER:
Doctors Farrokh Dehdashti and Barry Siegel are principal investigators in
studies involving PET, a 25-year-old technology developed at Mallinckrodt
Institute. Photography by Tim Parker.

SPOT NEWS
Highest honors
to Raichle
Marcus Raichle, MD,
professor of radiology and
codirector of the Division of
Radiological Sciences, is one
of 60 new members of the
National Academy of Sciences who were elected in
recognition of their distinguished and continuing
achievements in original
research. Election into the
Academy is one of the highest honors accorded a United
States scientist or engineer.
Established in 1863 by the
U.S. Congress, the Academy
acts an an official adviser to
the federal government in
matters concerning science
or technology.
As far back as 1971, at a
time when other neurosciences researchers were
unfamiliar with cyclotronproduced, short-lived
radionuclides, Raichle pioneered the use of these
nuclear medicine tools for
the measurement of cerebral

blood flow and metabolism.
For the past decade, his
research has focused on the
application of positron emission tomography to the study
of the human brain. That
research has produced
groundbreaking discoveries
in psychiatric disorders and
in the development of functional maps of the brain's
sensory and language information-processing areas.
Raichle holds joint
appointments as a professor
of neurology and of anatomy
and neurobiology. He is a
senior fellow with the
McDonnell Center for Studies of Higher Brain Function.
Raichle joined the Washington University Department of
Neurology in 1971 as a
research instructor and was
appointed professor of neurology in 1978. He was
named professor of radiology
in 1979 and professor of
anatomy and neurobiology in
1993. Raichle was appointed
in 1995 as codirector of
MIR's Division of Radiological Sciences.

Herman
assists
Ukrainian
radiologists
As a member of the
Friends of Ukrainian Radiology, pediatric radiologist
Thomas Herman, MD, associate professor of radiology,
recently traveled to the former Soviet state to participate in a symposium on
modern radiological imaging.
Hundreds of Ukrainian
physicians and medical students attended the symposium where Herman gave
talks on contemporary cranial sonography and Doppler
sonography in infants and on
contemporary imaging of
Wilms tumors and other
malignant renal tumors of
childhood.
While in the republic of
Ukraine, Herman spent two
days caring for patients at
the Lviv Regional Children's
Hospital, where he saw children with illnesses ranging
from bacterial infections to
acute leukemia to Burkitt
lymphoma. Because
Ukraine lacks even the most
basic modern medical necessities, like penicillin, a treatable infection often results in
a child's death.

Herman observed that
the citizens of Lviv, like most
other people in the regions
surrounding the site of the
1986 Chernobyl nuclear accident, attribute perceived
increases in disease to the
accident. However, based
on the scientific evidence
available, it seems much
more likely that any increase
in disease is the result of the
overall poor health of the
people in that region and the
primitive quality of the
Ukrainian medical system.
"The needs of the
Ukrainian radiology community are great because sonography and computerized
tomography have been introduced very recently to Lviv,
and magnetic resonance has
appeared only recently in
Ukraine," says Herman.
"Resources that physicians
in the United States take for
granted — books, journals,
equipment — are not easily
available to Ukrainian
doctors."
If you have medical
items to donate to the Lviv
Medical School and the
Ukrainian Association of
Radiologists, contact Herman at 314-454-6229.

Dennis Choi, MD, PhD, professor and head of the Department of Neurology, congratulates Marcus Raichle, MD, (right) on his election to the National Academy of Sciences.
James Blaine, DSc, head of MIR's electronic radiology lab, is in the background.
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Gold Medal
goes to Evens

[left to right) Dennis Balfe, MD, and Diagnostic Radiology residents Donald Heck, 1996-1997 chief resident; Eric Weidman, 1995■996 chief resident; Farrel VanWagenen, 1995-1996 cochief resident; and Thomas Vaughan, 1996-1997 chief resident, were on
hand for the presentation of the AUR Gold Medal to Dr. Ronald Evens (third from left).

[entors and
students
benefit
MIR's Summer
Research Program provides
medical students or science
undergraduates with
research experiences in one
of the many branches of
radiological sciences: contrast agent development,
digital imaging, diagnostic
radiology, magnetic resonance imaging, molecular
pharmacology, nuclear medicine, positron emission
tomography, and radiopharmaceutical development.
The program was begun in
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1993, and, according to Program Coordinator Carolyn
Anderson, PhD, assistant
professor of radiology, "provides an excellent way to
introduce students to radiological sciences research, a
field that they would have
very little exposure to in traditional science undergraduate or medical school
programs."
As part of this year's
program, six students were
paired with mentors, who
either served individually or
as part of a team, from the
divisions of Diagnostic
Radiology, Nuclear Medicine, and Radiological Sciences: James Brink, MD;
Thomas Conturo, MD, PhD;

Farrokh Dehdashti, MD; Jay
Heiken, MD; Elizabeth
McFarland, MD; Peter Shile,
MD; Celette Skinner, PhD;
Richard Slone, MD; and Ge
Wang, PhD. All reported
that the program was a
rewarding experience for
themselves as well as for
the students.
Applications for the
MIR Summer Research Program will be available in
November, with an application deadline of February.
Students will be notified of
their acceptance in March.
For further information,
contact Anderson by e-mail
(andersoncj @mirlink. wustl.
edu) or call 314-362-8427.

Annually, the Association of University Radiologists (AUR) presents the
Gold Medal in recognition
of outstanding contributions to the specialty of
radiology. Ronald Evens,
MD, director of Mallinckrodt Institute, was one of
two honorees to receive the
1996 award at the AUR
Annual Meeting on April 20
in Birmingham, Alabama.
The first AUR Gold Medal
was awarded in 1978, with
Dr. Hugh Wilson, the Institute's second director, as
one of the two recipients.
Evens, who is celebrating his 25th year as director
of the Institute, is noted for
his expertise in a variety of
radiologic technologies and
is highly regarded in business issues and the socioeconomics of medicine.
Under his direction, the
Institute underwent a major
expansion program and is
now one of the largest academic radiology departments
nationwide, with responsibility for more than 500,000
radiologic examinations per
year.
AUR is an international
organization of physicians
and scientists with university-granted faculty appointments in the fields of
radiology, radiation oncology, or nuclear medicine.
Established in 1953, the
AUR is the largest society of
university radiologists in the
world and is dedicated to
the promotion of excellence
in laboratory and clinical
investigation, teaching, and
clinical practice.

SPOT NEWS
Anderson
recognized by
Alumni
Association
Claire Anderson, MD,
was one of seven award
recipients honored by the
Alumni Association at Washington University School of
Medicine's (WUSM) Reunion
'96 banquet. The award recognized outstanding contributions to the field of
medicine and to WUSM.
Anderson, a 1971 medical
school alumna, joined the
MIR faculty in 1974. A professor of radiology in the
chest radiology section,
Anderson focuses her work
on clinical diagnostic radiology and is currently involved
in chest radiology for a large
group of patients in a lung
transplantation program.

NIH consensus
panel sets
protocol
At the urging of Perry
Grigsby, MD, professor of
radiology in MIR's Radiation
Oncology Center, the
National Institutes of Health
convened a consensus panel
in April to study the cause,
prevention, and treatment of
cervical cancer, one of the
most prevalent tumors in
women. The 13-member
panel found that wider use
of the Pap test, a diagnostic
procedure for detecting cervical cancer, could prevent
nearly all of the 15,000 new
cases of this disease that
occur each year in the
United States.
According to Grigsby,
"One of the most significant
findings of the panel is the
importance of routine Pap
tests. If every woman
received the Pap test, it
would dramatically reduce
the prevalence of this disease." Further research is
needed to establish methods
for reaching women who are
most at risk because they fail
to have the annual test —
the uninsured, women over
65, ethnic minorities, and
rural and poor women.
Because of a clear link
between human papillomavirus (HPV) infection and
cervical cancer, the panel

stressed the importance of
HPV vaccine research and of
educating women about HPV
prevention. Although most
women infected with the
sexually transmitted HPV
never experience serious
health problems, scientific
research has shown that a
small percentage of women
with HPV eventually develops invasive cancer.

The consensus panel
agreed on a protocol for
treating cervical cancer:
Hysterectomy or radiation
therapy is recommended for
early-stage cancers. In more
advanced tumors, radiation
therapy is the treatment of
choice. Chemotherapy is
also being evaluated as a
treatment option.

RADIOLOGY
Diagnosis • Treatment • Research

1895-1995
PRACTICAL ISSUES IN
LEADING-EDGE RADIOLOGY
OCTOBER

11-13.1996

I Symposium Sponsored by
The Mallinckrodt Institute of Radiology
ami the Washington I diversity
Off ice of Continuing Medical Education

Approved for 22.5 Hours of Category 1 CME Credit

Coll Linda Macker at 314-362-2916
for more information.
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■Wilson Award
Jpresented
Now in its 28th year, the
Wilson Award honors annually a Washington University
graduating medical student
who makes meritorious contributions to the Department
of Radiology. The award is a
tribute to Doctor Hugh Wilson,
su the second director of
e Institute, who advocated
he
h advancement of
education.
John Lim, the 1995-1996
recipient, worked in both
research and clinical capacities in abdominal radiology
under the mentorship of
James Brink, MD, associate
professor of radiology and
codirector of computed body
omography (CT). Lim first
egan working in abdominal
adiology during the summer
etween his first and second
years of medical school as a
participant in the research
elective program. He developed image-processing techniques to assess the accuracy
of spiral CT depiction of
renal arterial stenoses and
also worked closely with Ge
Wang, PhD, assistant professor of radiology and the CT
physicist, to implement novel
signal-processing techniques.
"John is highly motivated, innovative, and meticulous in the execution of his
research. His diligence
resulted in the rapid publication of a manuscript in the
journal Radiology," says
Brink. "John has an excellent fund of medical knowledge as well as a keen
interest in the problems
faced by diagnostic
radiologists."
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The research team: Michelle Miller, Doctors Tom Miller, Jerald Wallis, and Guang-ming Dai.

Newgeneration
algorithms
developed
Mallinckrodt Institute
has entered into a three-year
collaboration with Siemens
Nuclear Medicine Group to
market a new generation of
iterative reconstruction
algorithms developed by
researchers in MIR's Division of Nuclear Medicine.
Although coprincipal investigators Jerold Wallis, MD,
and Tom Miller, MD, PhD,
are only a year into their collaboration with Siemens, the
two have been researching
the new-generation algorithms for more than 10
years. The research uses
nuclear medicine images
obtained as part of a singlephoton emission computed
tomography (SPECT) study

and processes the images
with a computer program.
This program utilizes the
newly developed algorithms
to reconstruct a more accurate image than that available from current clinical
software.
"The innovations we've
developed at the Mallinckrodt Institute are designed
to dramatically speed up the
processor-intensive portions
of the algorithm such as reprojection and resolution
recovery. Faster convergence is a principal advantage of our algorithm," says
Wallis.
"Bringing improved
quantitative accuracy with
clinically acceptable reconstruction times to the clinical environment is the goal
of the project. The first generation of two-dimensional
algorithms with collimator-

specific resolution recovery
will be the platform for
launching incremental
improvements such as scatter correction and threedimensional reconstruction,"
adds Miller.
Until recently, it was
not feasible to use the new
algorithms clinically because
so much time was needed in
the image-reconstruction
process. Through their
research, Wallis and Miller,
aided by summer student
Michelle Miller and Postdoctoral Fellow Guang-ming
Dai, PhD, hope to complete
the computer processing of
a typical patient within 20
minutes, thus making the
algorithm suitable for clinical use. Clinical trials are
planned by the end of the
summer.
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David Piwnica-Worms, MD, PhD, and his

team of scientists at Mallinckrodt Institute of

Radiology (MIR) stand at a figurative Arc de

Triomphe, with innumerable research avenues

radiating in every direction. Some of these

roads provide the team with unforeseen

opportunities, others allow the export and

growth of their own discoveries. One thing is

true: The research itself is a virtual metropolis

of application and innovation and holds great

promise for improved patient care.

by Joanna B. Downer

Chemist Vijay Shormo, PhD, (left) and
David Piwnica-Worms, MD, PhD, head of
MIR's molecular radiopharmacology lab.

Piwnica-Worms
daily cross-checks
cell outtake samples.

Piwnica-Worms, an associate
professor of radiology at MIR
and an associate professor of molecular biology and pharmacology at
Washington University, focuses his
research on multidrug resistance
(MDR) in cancer and, more
recently, in infectious disease.
MDR is characterized by a tumor
cell that, after exposure to just a
single chemotherapeutic agent,
becomes nonresponsive to a whole
host of other agents, which may
only slightly resemble each other
chemically. One manifestation of
MDR tumors is the cell surface
presence of a large molecule, P-glycoprotein (Pgp), which spans the
cell membrane. Pgp is also present

in some normal tissues, such as the
liver and kidneys. In MDR, once
Pgp is activated by an MDR-inducing agent, the protein acts as a oneway highway, rapidly transporting
the administered drug and any
"member" drugs out of the cell,
explains Piwnica-Worms.
Multidrug resistance has a serious effect on cancer treatment
because many commonly used
chemotherapeutic agents induce
resistance in predisposed cells,
resulting in failed therapy and
fewer treatment options for the
patient. Knowledge of a patient's
MDR status prior to initialization of
treatment could result in a more
effective first line of therapy, and
this is where Piwnica-Worms and
his team are making their
contributions.

Piwnica-Worms arrived at the
study of MDR and Pgp almost
by chance. While on staff at Harvard Medical School's Brigham
and Women's Hospital, he began
examining the cellular uptake
mechanism of technetium-99mSESTAMIBI (99mTc-SESTAMIBI),
a compound used in cardiac perfusion imaging to measure and verify
blood flow to the heart muscle
using single photon emission computed tomography (SPECT).
Radioactive 99mTc decays by emitting a packet of energy, called a
photon, which is detected outside
of the body by a SPECT scanner.
A computer-generated image of the
decay process permits visualization
of the localization of the radiopharmaceutical within the body, without the physician ever having to
pick up a scalpel. Such noninvasive imaging techniques are
extremely beneficial in diagnosis
and evaluation of cancer and other
diseases.

MALLINCKRODT INSTITUTE OF RADIOLOGY

AN ATLAS OI

During this time, PiwnicaWorms found that 99mTC-SESTAMIBI is taken up by the cells,
then concentrated and retained in
tiny compartments within the cell
called mitochondria. The chemical
nature of Tc-SESTAMIBI is
lipophilic and cationic. Its
lipophilic, or fat loving, nature permits the compound to flow freely
across the cellular membrane and
into the cell. Tc-SESTAMIBI's
cationic, or positive, charge then
allows it to be transported into the
negatively charged interior of the
mitochondria. This process happens repeatedly, resulting in the
accumulation of a high level of the
radiopharmaceutical within the
mitochondria, where the compound
essentially becomes stuck.
In other tissues, such as the
liver and kidneys, Piwnica-Worms
found that the 99mTc-SESTAMIBI
was not retained as it was in the
heart. Instead it was extruded from
the cells at a very high rate, faster
than it could travel into the mitochondria. The reason for this
exporting of the radiopharmaceutical led Piwnica-Worms down the
road to multidrug-resistance
imaging.
Aware of Pgp presence in the
liver and kidneys, Piwnica-Worms
hypothesized that Pgp was responsible for the rapid clearance of
99mTC-SESTAMIBI from these
organs. Since this first discovery
that 99mTc_SESTAMIBI retention is
inversely related to the presence of
Pgp, the research team has undertaken exhaustive biochemical studies to prove without a doubt that
Pgp is responsible for the differences in tissue uptake.
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Piwnica-Worms and his team
came to MIR in August of 1994,
continuing their in-depth study of
the mechanism and behavior of Pgp
and 99mTc_sESTAMIBI. Biochemist
Carolyn Crankshaw, MS, examined
the relationship between uptake of
99mTc-SESTAMIBI and tumor-cell
lines with different levels of Pgp.
Vallabhaneni Rao, PhD, a biochemist, has been instrumental in
verifying the role of Pgp through
the use of human DNA transferred
into baculovirus, a DNA virus that
is made to infect insect cells in the
laboratory. It is then amplified for
proof of the connection between
the human gene, MDR1 (which
codes for the production of Pgp),
Pgp itself, and differences in99mTcSESTAMIBI uptake. As a result of
their painstaking work, 99mTc-SESTAMIBI is moving beyond heart
imaging.
Gary Luker, MD, a research fellow in Piwnica-Worms' laboratory,
has collaborated with Doctors
Nancy Bartlett and Paula Fracasso
of the Division of HematologyOncology and with Doctors Barry
Siegel and Henry Royal of the Division of Nuclear Medicine on a pilot
clinical trial using 99mTC-SESTAMIBI. During the study, baseline
images were obtained that showed
the expected rapid clearance of
99mTc-SESTAMIBI from the liver
and kidney. Administration of a
high potency Pgp reversal agent
(called PSC 833 and provided by
Sandoz Pharmaceuticals) and subsequent reinjection of 99mTc-SESTAMIBI resulted in the
accumulation and prolonged retention of the imaging agent in those
tissues, as if Pgp were no longer
functioning. This is the same result
we hope to find in tumors, says
Piwnica-Worms. A multicenter
Phase lb clinical trial using a different modulator is about to begin, he
adds.

f
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This pilot study verified that
99mTc-SESTAMIBI can distinguish
between Pgp expressing (multidrug
resistant) and non-Pgp expressing
(drug sensitive) tissue. In addition,
it aided Sandoz in validating PSC
833 as a useful modulator, a compound which blocks the Pgp route
out of the cell and allows retention
of the normally Pgp-affected drugs
(99mTc-SESTAMIBI in this case)
within their intracellular targets.
It is this kind of two-way street
between clinical and scientific
research that is typical of PiwnicaWorms' collaborations, as well as
the nature of the project itself.
Modulators come in from the clinical side and rendezvous with
Piwnica-Worms' well-characterized
Pgp imaging agent, resulting in the
validation of both the modulator
and the radiotracer used to create
the image. Although many modulators are in clinical trials, no com-

pound is in standard practice.
99mTc-SESTAMIBI is an excellent
way to noninvasively measure the
efficacy of the modulators in clinical trials.
As a result of the promising
work with 99mTc_SESTAMIBI,
Piwnica-Worms has obtained a
grant from Mallinckrodt Medical
Inc. to evaluate a series of 99mTc
compounds known as Q complexes, which were initially developed as cardiac agents. In this

Knowledge of a
patient's MDR status
prior to initialization of treatment
could result in a
more effective first
line of therapy.
collaboration, Piwnica-Worms
salutes the openness of his collaborators Doctors Dan Burleigh, Mary
Marmion, and Karen Deutsch, and
Mallinckrodt Medical as a whole.
"This has been an excellent twoway academic and industrial relationship and is a testimonial to
their willingness to share and build
on important data and information," commends Piwnica-Worms.

Biochemist Vailabhaneni Rao evaluates a Western
blot of the molecule P-glycoprotein in cancer cells.
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With assistance by Research
Technologist Julie Dahlheimer,
approximately 40 of these Q complexes have been tested for Pgp
activity by the techniques developed by Crankshaw, Rao, and
Luker. Three or four of these compounds exceed 99n»Tc-SESTAMIBI's
Pgp distinction characteristics in
cell models. Additional studies are
now underway to further evaluate
the most promising candidates for
MDR Pgp imaging. If the project
continues to move forward, pilot
evaluation in patients could begin
within a year, says Piwnica-Worms.
Having migrated to the realm of
discovery and development of
new radiopharmaceutical imaging
agents for Pgp, Piwnica-Worms and
his coworkers began building a
path to synthesize and to evaluate
a series of new radiotracers.
Chemist Vijay Sharma, PhD, is
responsible for synthesizing this
new generation of complexes,
known as N402 compounds.
Unlike SESTAMIBI, these compounds possess a broad flexibility
to incorporate a variety of metals
besides 99mTc, which opens roads
to a number of other uses.
Incorporation of gallium-68, a
positron-emitting metal, into these
compounds will permit the use of
positron emission tomography
(PET) for visualizion of the MDR
tumors. PET offers the opportunity for quantitative functional
imaging of biological processes,
which would increase knowledge
of the circumstances responsible
for induction of MDR activity by
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chemotherapeutics and subsequent reversal by modulators —
an area little understood. This
research is in collaboration with
Doctors Michael Welch, Laura
Bass, and David Reichert of MIR's
Division of Radiological Sciences.
Beyond diagnostic imaging,
use of iron (Fe) as the metal in
these N402 complexes may lead to
their use as therapeutic agents for
MDR. It may be possible to modify the
functional groups on
the basic N402 structure in a way that
would permit the FeN402 complex to
block the Pgp exit
route, resulting in a
reversal of the MDR
activity, says
Piwnica-Worms.
In fact, PiwnicaWorms' ongoing collaboration with
Doctor Daniel Goldberg of the
Department of Molecular Microbiology resulted in a study of the
therapeutic effect of these iron
compounds in drug-resistant
malaria, an infectious disease
whose MDR activity may be due to
a Pgp-related protein. One of the
fortunate characteristics of all of
these Pgp agents is that after proving their transport connection to
Pgp, they can be used to study
MDR itself, both in cancer and in
infectious disease.
"We have the pleasure of
working on both sides of the interface between chemistry and cell
biology. We can develop and validate novel agents and then turn
them around to probe biological
transport function," explains
Piwnica-Worms.
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These MDR Pgp imaging agents
will be of great use to both nuclear
medicine physicians and their
patients. Groups around the world
have begun to realize the advantages of identifying MDR status
early using the available 99mTc-SESTAMIBI. One of the major benefits
of MDR Pgp imaging agents may be
improved estimation of prognosis
and risk at initial presentation or
recurrence of disease, says
Piwnica-Worms.
1

everal studies indicate that if
Hhe patient's tissues contain
Ot
Pgp, there is a high correlation with
poor outcome and early treatment
failure. Conversely, when Pgp is
not present in the tissue, the
patients have better outcomes and
longer remissions. This has been
shown for a wide variety of cancer
types," explains Piwnica-Worms.
Knowledge of MDR status
would affect choice of therapy as
well. If MDR were present, selection of chemotherapeutic agents
known to be affected by Pgp would
be curtailed, since failure of such
drugs would be imminent without a
modulator. If no modulator was
available, alternative agents that
are not transported by Pgp would
be used from the beginning of therapy. "It would be quite desirable if
we can increase the probability
that the chemotherapy chosen for
the patient will be successful,"
Piwnica-Worms emphasizes.

12

Ron Dolin, an undergraduate student

One of the major
benefits of MDR Pgp
imaging agents may
be improved estimation of prognosis and
risk at initial presentation or recurrence
of disease.

at Washington University, assists Rao
in verifying the presence of Pgp tumor
cells.

I
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In addition, any of these imaging agents — 99mTc-SESTAMIBI,
the Q complexes, or the N402 complexes — could be used to monitor the effectiveness of modulators
administered in an attempt to
reverse the MDR activity of the
tumor. During chemotherapy treatment the modulators close the Pgp
export path, allowing the
chemotherapy drug to reach its cellular destination. The imaging
agent essentially tracks the
chemotherapeutic drug, so that
retention of radioactivity in the
tumor verifies the efficacy of the
modulator, explains PiwnicaWorms.
The broad distribution of MDR
in tumors of various types, as
well as in infectious disease, provides a significant population of
patients who would benefit from
development of both Pgp imaging
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agents and modulators. Among its
many applications, Piwnica-Worms'
work in developing and testing
imaging agents improves the ability
to evaluate modulators in patients.
The diverse nature of PiwnicaWorms' research is supported by his
presence here at MIR and Washington University. "The facilities, the
equipment, the collaborative relationships we've been able to
develop at Washington University
have really been a major step forward for the breadth and quality of
our research program. A lot of the
things we've been able to do have
been a product of the multifaceted
environment here," says PiwnicaWorms.
In Piwnica-Worms' research,
the roads of biology, chemistry, and
clinical and molecular medicine
intersect. Because of PiwnicaWorms' philosophy of rigorous and
extensive characterization and veri-

fication at each step along the way,
from drug development and synthesis to screening in cells to evaluation in patients, the road to MDR
Pgp imaging will be well-traveled
by the time he is through. EH
Editor's note: Joanna Downer is a
chemistry graduate student conducting research in MIR's Division of
Radiological Sciences.

Research Technologist Julie Dahlheimer checks tissue
cultures of cancer cells that contain different levels of
the multidrug resistance molecule Pgp.
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woman with a suspicious lump in her breast has to hold her breath tv ice.

♦

twice

WOMAN WITH A SUSPICIOUS LUMP IN HER BREAST HAS TO HOLD HER
BREATH TWICE.

FIRST, SHE MUST UNDERGO A SURGICAL BIOPSY TO SEE

WHETHER THE LUMP IS MALIGNANT. AND AFTER THE CANCER IS DIAGNOSED,
SHE AGONIZES WHILE SHE AWAITS THE RESULTS OF A SECOND SURGICAL PROCEDURE:

A LYMPH-NODE DISSECTION THAT WILL SHOW WHETHER OR NOT THE

CANCER HAS SPREAD AND HOW MANY NODES ARE AFFECTED.

PET

THESE FINDINGS ARE CRITICALLY IMPORTANT TO HER FUTURE.

IF HER

AXILLARY LYMPH NODES ARE FREE OF CANCER, SHE CAN EXPECT A 10-YEAR
SURVIVAL RATE OF ABOUT 70 PERCENT; IF CANCER IS PRESENT, THE SURVIVAL
RATE DROPS TO 30 PERCENT.

THE NUMBER OF CANCEROUS NODES IS ALSO

CRUCIAL, SINCE PATIENTS WITH FOUR OR MORE POSITIVE NODES HAVE A MUCH
POORER PROGNOSIS THAN PATIENTS WITH FEWER AFFECTED NODES.
A NEW STUDY AT MALLINCKRODT INSTITUTE OF RADIOLOGY AND TWO
OTHER CLINICAL SITES WILL SOON BE TESTING WHETHER OR NOT THERE IS AN
ACCURATE, ECONOMICAL, AND NONINVASIVE WAY TO EVALUATE LYMPH-NODE
METASTASIS USING POSITRON EMISSION TOMOGRAPHY (PET). THE MULTICENTER STUDY, SUPPORTED BY A $2.8 MILLION GRANT, IS THE FIRST OF ITS KIND
FUNDED BY THE NATIONAL CANCER INSTITUTE (NCI) FOR THE EVALUATION OF

THE EFFECTIVENESS OF PET SCANS IN CANCER DIAGNOSIS,

by Candace O'Connor

PET: A Logical Tool in the Fight Against Breast Cancer

women will benefit

Barry Siegel, MD, director of the Division of Nuclear Medicine and principal investigator for the St. Louis site, says the outcome of this study
could have great significance for women with breast cancer. Right now,
surgery is the only option for evaluating lymph-node involvement. But
surgery is expensive and uncomfortable, and it also entails some risks, such
as infections and long-term swelling.
"Avoiding the expense and discomfort of axillary dissection is an important goal, and PET seems a logical tool for achieving that goal," he says.
"We're very glad we have the opportunity to evaluate PET's effectiveness in
this study."
Along with the lymph-node study, a second
breast-cancer initiative — also funded by the NCI —
is underway in the Division of Nuclear Medicine,
with Farrokh Dehdashti, MD, assistant professor of
radiology, as the principal investigator. This study,
which focuses on patients with advanced breast
cancer with estrogen-receptor-positive tumors, will
try to predict more accurately which women will
benefit from hormonal therapy.
Both studies rely on PET, a noninvasive, imaging technique developed in the early 1970s by a
team of Mallinckrodt Institute researchers led by
the late Dr. Michel Ter-Pogossian. PET provides
vivid functional images of various organ systems. In
earlier studies, it has proven to be a sensitive tool
for distinguishing benign tissue from malignant tissue and for detecting the spread of cancerous
tumors.

Doctors Siegel and Dehdashti examine PET images of
breast cancer with Duffy Cutler, PhD, a nuclear
medicine physicist.

PET: A Logical Tool
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MIR;

researchers began planning the lymph-node study nearly five
tyears. ago, when the U.S. Army announced a new funding program for breast-cancer research. But their first application for funding was
not successful. When a second Army initiative was announced, Siegel
joined forces with MIR alumni Edward Coleman, MD, of the Duke University Medical Center and Richard Wahl, MD, of the University of Michigan
Medical Center, and resubmitted the proposal. Although the study received
a highly favorable review, it was once again not funded.
The three institutions rewrote the grant and submitted it to the NCI with
Wahl as the overall principal investigator. Two institutions were added to
the study: the American College of Radiology Clinical Trials Division for
data management and the Brown University Medical School for help with
statistical analysis. Last September, the grant was funded; the MIR group's
portion of the funding is a total of $620,000. Since then, says Siegel, the
investigators have spent several months finalizing the protocol, preparing
forms for data gathering, and working out electronic data submission
issues. Patient recruitment began in July.
MALLINCKRODT INSTITUTE OF RADIOLOGY

"We're looking for women with primary breast cancer, who have not
yet had an axillary dissection but are scheduled for one," says Siegel. "They
should not have had any therapy — chemotherapy, hormonal therapy, or
radiation — prior to the axillary dissection."
A designated surgeon at each study site will refer patients to the
researchers and serve as a contact for other surgeons who might also be a
source of patients. Diane Radford, MD, is the surgical contact for the MIR
group; other members of the team include Doctors Dehdashti and Peter
Humphrey of the Department of Pathology, a research coordinator, a physicist, and several technologists. The three sites hope to scan 414 women
(138 women at each center) over a 30-month period.
Women recruited for the study will be imaged with PET after receiving
an injection of F-18 fluorodeoxyglucose (FDG), a radioactive form of sugar
that is taken up more avidly, and retained longer, by malignant tissues than
by normal tissues. Earlier studies have reported preliminary success using
PET and FDG to detect cancer in the axillary nodes of small numbers of
patients with newly diagnosed breast cancer.
This new, larger-scale study will compare PET results with the outcome of the surgical biopsies, which the women will undergo soon afterwards. "Our first goal is to determine the sensitivity and specificity of PET
in detecting axillary nodal metastasis." says Siegel. "The second goal is to
see whether or not PET-derived estimates of the extent of metastatic disease in the axillary nodes and also in the internal mammary nodes provide
prognostic information that we couldn't obtain with standard, invasive staging methods."
In a study variation, some 45 patients with large tumors, who will
receive chemotherapy before their axillary dissections, will also have PET
scans prior to their treatment and biopsies. "We decided that although we
wouldn't be able to use these patients to assess how reliable PET is in
detecting the disease, because the pathology will be changed by the intervening chemotherapy, we do need to find out if PET is providing reliable
prognostic information in these patients with more advanced tumors," says
Siegel.

"AVOIDING THE EXPENSE AND
DISCOMFORT OF AXILLARY DISSECTION IS AN IMPORTANT GOAL,
AND PET SEEMS A LOGICAL TOOL
FOR ACHIEVING THAT GOAL."
—

BARRY SIEGEL,

MD

the sensitivity of PET

To gather prognostic information, researchers plan to follow up with all
patients over the five-year life of the study to look for any signs of
recurrence. The referring surgeons will not know any of the results, unless
PET turns up a life-threatening condition such as a metastasis that has progressed beyond the lymph nodes but is unsuspected clinically.
If this study proves successful, the researchers may next apply for
funds to evaluate the use of gamma cameras, which are more widely available than PET scanners, in assessing nodal metastasis. Meanwhile, says
Siegel, "for an investigator-initiated grant, this was an unusually large funding. We're proud of that. Now we've got to make it the best possible study
to prove that the confidence placed in us was justified."
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better quality of life

"TWO-THIRDS OF PATIENTS WITH
BREAST CANCER HAVE EXPOSITIVE TUMORS, BUT ONLY FIFTY
OR SIXTY PERCENT WILL RESPOND
TO

HORMONAL
—

THERAPY."

FARROKH DEHDASHTI,

MD

As the lymph-node project gets underway, the study directed by
Dehdashti, in collaboration with Siegel; Joanne Mortimer, MD, of the
Division of Hematology/Oncology; and a group of referring clinicians, is
also just beginning. This research, supported by a four-year, $1.7 million
NIH grant, will involve 60 women, all of whom have locally advanced
tumors that have proven through in vitro analysis to be estrogen-receptor
(ER) positive. Estrogen, a naturally occurring hormone, is strongly suspected of being a cause for the growth of cancerous cells in the breast.
"Two-thirds of breast-cancer patients have ER-positive
tumors," says Dehdashti. "But only fifty or sixty percent will
respond to hormonal therapy. Nobody knows why. So we
are trying to find out if our imaging compound, which shows
the functional status of these receptors, can better identify
those patients who would respond to hormonal therapy."
In the study, patients will be injected with both FDG (the
radioactive form of sugar used in Siegel's study) and F-18 fluoroestradiol (FES), a radioactive form of a natural estrogen.
Then the patients will be imaged with PET before and after
^ the start of tamoxifen therapy, an anti-estrogen drug. The
•^M
hypothesis is that the tamoxifen will initially have an agonistic effect, causing an increase in the FDG uptake in the tumor
and making it appear that the tumor is getting worse. But if
the FES uptake goes down at the same time, the tamoxifen
may be blocking the uptake in the tumor — when in actuality the tumor is
getting better. If the FDG uptake increases and the FES uptake either does
not change or decreases only minimally, the tamoxifen may not be working
and the disease may be progressing.
Being able to tell early on whether or not hormonal therapy is working
will also benefit a small percentage of patients who experience a clinical
problem called the "flare reaction." Typically, a week or two after the start
of treatment, the patient with flare reaction has an increase in pain or
swelling of the tumor. Clinically, it may be difficult to distinguish a flare
reaction from disease progression. Therefore, the physician may decide
the tamoxifen is not working and then starts the patient on chemotherapy.
But, in fact, the agonistic effect is transiently causing the tumor to grow
until the antagonistic effect kicks in, and the patient begins to improve.
"If we prove our hypothesis, we will be providing unique information
about therapy," says Dehdashti. "Hormonal therapy is less toxic than
chemotherapy, which can make patients very ill. If the clinician prematurely stops the hormonal therapy, this action actually takes away the
patient's opportunity for a better quality of life." EM
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PROMOTIONS
Carlos Aquino-Aponte,
MD, instructor in radiology,
Iwas promoted to assistant
rofessor of radiology, Division of Diagnostic
Radiology.
Wiilliam Dawson, MD,
as:sistant professor of radiology, was promoted to associate professor of radiology,
ivision of Diagnostic
adiology.
lomas Herman, MD,
ssistant professor of radiology, was promoted to associate professor of radiology,
Division of Diagnostic
Radiology.
ssen Kirov, PhD, research
associate, was promoted to
instructor in radiology, Radiation Oncology Center.
William Mehard, MD,
instructor in radiology, was
promoted to assistant professor of radiology, Division
of Diagnostic Radiology.

Linda Proctor, MD,
instructor in radiology, was
promoted to assistant professor of radiology, Division
of Diagnostic Radiology.
David Reichert, PhD,
research associate, was promoted to research instructor
in radiology, Division of
Radiological Sciences.
Dmitriy Yablonskiy, PhD,
research associate, was promoted to research instructor
in radiology, Division of
Radiological Sciences.

JOINT APPOINTMENTS
Thomas Conturo, MD,
PhD, assistant professor of
radiology, received a joint
appointment as an adjunct
assistant professor of
physics.

James Duncan, MD, PhD,
assistant professor of radiology and of cell biology and
physiology, is a fellow in vascular and interventional radiology. He was a radiology
resident (cochief resident,
1993-1994) and research
instructor at Mallinckrodt
Institue of Radiology. Duncan is a member of Alpha
Omega Alpha.

FIRST-YEAR FELLOWS

Richard Edelstein, MD, is
a fellow in vascular and
interventional radiology. He
completed a four-year diagnostic radiology residency at
Mallinckrodt Institute of
Radiology and is a member
of Alpha Omega Alpha.

Mary Alderman, MD,
instructor in radiology, is a
fellow in vascular and interventional radiology. She
completed four years of
training in diagnostic radiology at Mallinckrodt Institute
of Radiology and is a member of Alpha Omega Alpha.

Matthew Fleishman, MD,
instructor in radiology, is a
fellow in chest radiology. He
completed a four-year diagnostic radiology residency at
Mallinckrodt Institute of
Radiology. Fleishman is a
member of Alpha Omega
Alpha.

NEW STAFF

Robert Buse, MD, instructor in radiology, is a fellow in
neuroradiology. He received
an undergraduate degree
from Xavier University,
Cincinnati, Ohio, and a medical degree from the University of Cincinnati. Buse
completed a four-year residency in diagnostic radiology at Vanderbilt University,
Nashville, Tennessee, and is
a member of Alpha Omega
Alpha.
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Serge Djukic, MD, instructor in radiology, is a fellow in
neuroradiology. He received
an undergraduate degree
from Peta Beogradska Gimnazija and a medical degree
from the University of Belgrade, Yugoslavia. Djukic
completed four years of
training in diagnostic radiology at the University of California, San Diego.

Jeffrey Friedland, MD,
instructor in radiology, is a
fellow in pediatric radiology.
He completed a four-year
diagnostic radiology residency at Mallinckrodt Institute of Radiology. He is a
member of Alpha Omega
Alpha.

David Gius, MD, PhD,
instructor in radiology, is the
1996-1997 American Society
for Therapeutic Radiology
and Oncology (ASTRO) fellow in radiation oncology.
He completed two years of
residency in radiation oncology at Mallinckrodt Institute
of Radiology.
Annette Johnson, MD,
instructor in radiology, is a
fellow in neuroradiology.
She received an undergraduate degree from The College
of William and Mary,
Williamsburg, Virginia, and a
medical degree from The
Medical College of Virginia.
Johnson completed four
years of training in diagnostic radiology at Glessinger
Medical Center, Danville,
Pennsylvania.
David Linkhous, MD,
instructor in radology, is a
fellow in musculoskeletal
radiology. He received an
undergraduate and a medical
degree from the University
of Virginia, Charlottesville.
Linkhous completed an
internship at Letterman
Army Medical Center, San
Francisco, California, and a
diagnostic radiology residency at the University of
California, San Francisco.
Lee Madeline, MD, instructor in radiology, is a fellow in
neuroradiology. He received
an undergraduate degree
from the University of Michigan, Ann Arbor, and a medical degree from Vanderbilt
University, Nashville, Tennessee. Madeline completed
a four-year diagnostic radiology residency at Bowman
Gray Medical College, Winston-Salem, North Carolina.
He is a member of Alpha
Omega Alpha.
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Eric Maiden, MD, instructor in radiology, is a fellow in
vascular and interventional
radiology. He completed
four years of training in diagnostic radiology at Mallinckrodt Institute of Radiology.

School, Norfolk. Shafaie
completed a four-year diagnostic radiology residency at
Eastern Virginia Medical
School Hospital, Norfolk.
He is a member of Alpha
Omega Alpha.

Randolph Pawluk, MD,
instructor in radiology, is a
fellow in magnetic resonance imaging. He received
undergraduate and medical
degrees from the University
of Alberta, Edmonton.
Pawluk completed an internship at the Royal Alexandra
Hospital, Alberta, Edmonton,
Canada, and a residency at
the University of Alberta
Hospital. He is a member of
Alpha Omega Alpha.

Mel Sharafuddin, MD,
instructor in radiology, is a
fellow in vascular and interventional radiology. He
received undergraduate and
medical degrees from the
University of Beirut,
Lebanon. Sharafuddin completed an internship at the
University of Iowa Hospital
and Clinics, Iowa City, and a
residency at St. Louis University Health Sciences Center, St. Louis, Missouri. He
is a member of Alpha Omega
Alpha.

Rory Satterfield, MD,
instructor in radiology, is a
fellow in abdominal radiology. He completed a fouryear diagnostic radiology
residency at Mallinckrodt
Institute of Radiology.
Michele Semin, MD,
instructor in radiology, is a
fellow in abdominal radiology. She completed four
years of training in diagnostic radiology at Mallinckrodt
Institute of Radiology.
Farid Shafaie, MD, instructor in radiology, is a fellow in
neuroradiology. He received
undergraduate degrees from
the University of Texas, San
Antonio, and from the University of Delaware, Newark,
and a medical degree from
Eastern Virginia Medical
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Leland Tsao, MD, instructor in radiology, is a fellow
in magnetic resonance imaging. He received an undergraduate degree from the
University of Virginia, Charlottesville, and a medical
degree from the Medical
College of Virginia, Richmond. Tsao completed an
internship at the Mayo
Clinic, Rochester, Minnesota, and a four-year diagnostic radiology residency at
Vanderbilt University,
Nashville, Tennessee. He is
a member of Alpha Omega
Alpha.

Farrel VanWagenen, MD,
instructor in radiology, is
a fellow in vascular and
interventional radiology.
He completed four years
of training in diagnostic
radiology and was cochief
resident, 1995-1996, at
Mallinckrodt Institute of
Radiology. VanWagenen is
a member of Alpha Omega
Alpha.
Steven Winn, MD, instructor in radiology, is a fellow
in abdominal radiology. He
completed three years of
training in diagnostic radiology at Mallinckrodt Institute
of Radiology. Winn is a
member of Alpha Omega
Alpha.
Robert Wissman, MD,
instructor in radiology, is a
fellow in musculoskeletal
radiology. He received an
undergraduate degree from
the University of Cincinnati
and a medical degree from
Ohio State University,
Columbus. Wissman completed a four-year diagnostic
radiology residency at Ohio
State University, Columbus.

FIRST-YEAR POSTGRADUATES
Mark Fister, MD, assistant
in radiology, received an
undergraduate degree from
the University of Illinois,
Urbana, and a medical
degree from the University
of Kentucky, Lexington. He
is a member of Alpha Omega
Alpha.
Jon Fromke, MD, assistant
in radiology, received an
undergraduate degree from
Wheaton College, Illinois,
and a medical degree from
University of Minnesota,
Minneapolis. He is a member of Alpha Omga Alpha.

Mark Oswood, MD, assistant in radiology, received an
undergraduate degree from
St. Olaf College, Northfield,
Minnesota, and a medical
degree from Yale University,
New Haven, Connecticut.
Bartosz Rydzewski, MD,
assistant in radiology,
received an undergraduate
degree from K. Marcinkowski
Memorial, Poznan, Poland,
and a medical degree from
Vanderbilt University,
Nashville, Tennessee. He is
a member of Alpha Omega
Alpha.

FIRST-YEAR DIAGNOSTIC
RADIOLOGY RESIDENTS
Donald Blair, MD, assistant
in radiology, received an
undergraduate degree from
the University of Chicago
and a medical degree from
Columbia College of Physicians and Surgeons, New
York City. He completed a
one-year transitional internship at the University of
Hawaii, Honolulu.
Mary Board, MD, assistant
in radiology, received an
undergraduate degree from
Miami University, Oxford,
Ohio, and a medical degree
from Washington University
St. Louis, Missouri. She
completed a one-year intern
ship at BarnesJewish
Hospital, St. Louis, Missouri
Hank Chen, MD, assistant
in radiology, received an
undergraduate degree from
the University of California,
Berkeley, and a medical
degree from University of
California, Los Angeles. He
completed a one-year intern
ship at St. Vincent's Hospital
New York City. Chen is a
member of Alpha Omega
Alpha.
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Timothy Davis, MD, assistant in radiology, received an
undergraduate degree from
Indiana University, Bloomington; a masters degree and
i doctorate from Massachusetts Institute of Technology,
Cambridge; and a medical
degreefrom Harvard University, Cambridge,
/lassachusetts.
Terry Falk, MD, assistant
in radiology, received an
undergraduate degree from
University of North Dakota,
Grand Forks, and a medical
degree from Universit of
Minnesota, Minneapolis. He
completed a one-year transitional internship at Hennepin
County Medical Center, minfneapolis, Minnesota. Falk is
a member of Alpha Omega
Alpha.
Anthony Hein, MD, assistant in radiology, received an
undergraduate degree from
Stanford University, California, and a medical degree
from University of California, Los Angeles. He completed an internship at
Cedars-Sinai Medical Center,
Los Angeles, California.
Hein is a member of Alpha
Omega Alpha.
David Jeck, MD, assistant
in radiology, received an
undergraduate degree from
University of Pennsylvania,
Philadelphia, and a medical
degree from the University
of Arizona, Tucson. He completed an internship at Good
Samaritan Regional Center,
Tucson. Jeck is a member of
Alpha Omega Alpha.
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Radiation
Oncology
Center
Alfred Tinger, MD, is the
1996-1997 radiation
oncology chief resident.
He received an undergraduate degree in
physics from the State
University of New York
at Binghamton and a
medical degree from the
State University of New
York Health Center at
Brooklyn.

Leo Lawler, MD, assistant
in radiology, received an
undergraduate and a medical
degree from the University
of Dublin, Ireland. He completed an internship at St.
Vincent's University
Hospital, Dublin, Ireland,
and at Mayo Clinic,
Rochester, Minnesota.

Pratik Mukherjee, MD,
assistant in radiology,
received an undergraduate
degree from Yale University,
New Haven, Connecticut,
and a medical degree from
Cornell, University, Ithaca,
New York. He completed an
internship at New York
Hospital,

Jason Levy, MD, assistant
in radiology, received an
undergraduate degree from
Washington University, St.
Louis, Missouri, and a medical degree from New York
University, New York. He
completed an internship at
Lenox Hill Hospital, New
York City.

Harold Prow, MD, assistant
in radiology, received an
undergraduate degree from
Vanderbilt University,
Nashville, Tennesse, and a
medical degree from Baylor
University, Waco, Texas. He
completed an internship at
the University of Hawaii,
Honolulu. Prow is a member
of Alpha Omega Alpha.

Agnes Santosa, MD, assistant in radiology, received
an undergraduate degree
from Massachusetts Institute
of Technology, Cambridge,
and a medical degree from
Stanford University, California. She completed aninternship at Kaiser
Permanente, Santa Clara,
California.
Stephen Schmitter, MD,
assistant in radiology,
received an undergraduate
degree from University of
Michigan, Ann Arbor, and a
medical degree from Stanford University, California.
He completed an internship
at Mercy Hospital and Medical Center, San Diego,
California.
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FIRST-YEAR NUCLEAR
MEDICINE TRAINEES
Edward Grishaw, MD,

assistant in radiology,
received an undergraduate
degree from the University
of Texas, San Antonio, and a
medical degree from the University of Texas Health Science Center, San Antonio.
He completed a four-year
diagnostic radiology residency at Bowman Gray
School of Medicine, Winston-Salem, North Carolina.
Grishaw is a member of
Alpha Omega Alpha.
Anton Johnson, MD, assistant in radiology, received an
undergraduate degree and a
medical degree from University of Minnesota, Minneapolis. He completed a
four-year diagnostic radiology residency at University
of Minnesota,Minneapolis.
Johnson is a member of
Alpha Omega Alpha.
Brigid Gordon, MD, assistant in radiology, received an
unergraduate degree from
Chestnut Hill College,
Philadelphia, Pennsylvania,
and a medical degree from
Georgetown University,
Washington, DC. She completed a four-year diagnostic
radiology residency at Duke
University Medical Center,
Durham, North Carolina.
Gordon is a member of
Alpha Omega Alpha.

Louis Winner, MD, assistant in radiology, received an
undergraduate degree from
Emory University, Atlanta,
Georgia, and a medical
degree from University of
Texas, Dallas. He completed
an internship and a residency at Baylor University
Medical Center, Waco,
Texas.
FIRST-YEAR RADIATION
ONCOLOGY RESIDENTS
Samuel Au, MD, PhD,

assistant in radiology,
received an undergraduate
degree from Massachusetts
Institute of Technology,
Cambridge; a masters degree
from University of Southern
California, Los Angeles; a
masters degree and a doctorate degree from University
of Illinois, Urbana; and a
medical degree from University of California, Davis. He
completed an internship at
San Bernadino County Medical Center, California.
Heather Curry, MD, assistant in radiology, received an
undergraduate degree from •
Bryn Mawr College, Bryn
Mawr, Pennsylvania, and a
medical degree from Temple
University, Philadelphia,
Pennsylvania. She completed an internship at
Abington Hospital, Abington,
Pennsylvania.

Noushin Izadifar, MD,
assistant in radiology,
received a medical degree
from Shiraz University, Shiraz, Iran. She completed a
transitional internship at
Ghasm Hospital, Mashad,
Iran, and six months of residency in radiation oncology
at Jorjani Hospital, Tehran,
Iran.
Dotun Oyedijo, MD, assistant in radiology, received an
undergraduate and a medical
degree from University of
Michigan, Ann Arbor. He
completed an internship at
Oakwood Hospital and Medical Center, Dearborn,
Michigan.

OFF STAFF
Kim Baker, MD, instructor
in radiology, completed a
two-year fellowship in neuroradiology and has
accepted a position with
Hahnemann University
Hospital, Philadelphia,
Pennsylvania.
Robert Brown, PhD, visiting professor of radiology,
Division of Radiological
Sciences.
Gregory Cizek, MD,
instructor in radiology, completed a two-year fellowship
in neuroradiology and has
entered private practice in
St. Louis, Missouri.
Glenn Coates, MD, instructor in radiology, completed a
one-year fellowship in magnetic resonance imaging and
has accepted a position with
Wake Radiology, Raleigh,
North Carolina.
Wayne Drevets, MD, assistant professor of radiology,
Division of Radiological
Sciences.

John Felker, MD, assistant
in radiology, completed four
years of training in diagnostic radiology and has
accepted a position with
Greenview Regional Hospital
Radiology Consultants,
Bowling Green, Kentucky.
Andrew Fisher, MD, assistant in radiology, completed
four years of training in diagnostic radiology and has
received a body imaging fellowship at Duke University
School of Medicine, Durham,
North Carolina.
Kenneth Ford, MD,
instructor in radiology, completed a one-year fellowship
in abdominal radiology and
has accepted positions as a
staff radiologist at Baylor
University Medical Center,
Waco, Texas, and as medical
director at Texas Diagnostic
Imaging Center, Mesquite.
Anthony Foti, MD, assistant in radiology, completed
four years of training in diagnostic radiology and has
received an abdominal/body
imaging fellowship at Duke
University School of Medicine, Durham, North
Carolina.
Donald Frei, MD, instructor in radiology, completed a
two-year fellowship in neuroradiology and has
accepted a position with
Texas Neuroradiology PA,
Dallas.
Arjun Godhwani, PhD,
adjunct research associate,
Division of Radiological
Sciences.
PhiUip Gunther, MD,
instructor in radiology, completed a one-year fellowship
in magnetic resonance imaging and has accepted a position with Diagnostic Imaging
Northwest, Tacoma,
Washington.
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Robert Kanterman, MD,
structor in radiology, completed a one-year fellowship
i vascular and intervenf
tional radiology and has
accepted a position with St.
Luke's Hospital, Chesterfield, Missouri.

Mitchell Miller, MD, instructor in radiology, completed a
four-year diagnostic radiology
residency and a one-year fellowship in abdominal radiology. He has accepted a
position with Atlantic Radiologists, Domona, New Jersey.

Todd Knapp, MD, assistant
in radiology, completed one
year of training in diagnostic
radiology.

Astrid Morrison, MD, assistant in radiology and chief resident, Radiation Oncology
Center, 1995-1996, completed
three years of residency and a
one-year fellowship in radiation oncology. She has
entered private practice in
Oklahoma City, Oklahoma.

Keith Kronemer, MD,
instructor in radiology, completed a one-year fellowship
in pediatric radiology and
has accepted a position with
| Christ Hospital Medical Cen1 ter, Oak Lawn, Illinois.
Cenneth Larson, PhD,
| research associate, Division
of Radiological Sciences.
I Henry Lee, MD, instructor
in radiology, has accepted a
position with The Radiation
| Oncology Center of Las
Vegas, Sunrise Hospital, Las
:
Vegas, Nevada.
Stephen Loehr, MD, assistant in radiology, completed
one year of training in diagnostic radiology.
Gary Luker, MD, instructor
in radiology, completed four
years of training in diagnostic radiology and a one-year
fellowship in pediatric radiology. He has accepted a
position with Mallinckrodt
Institute of Radiology, St.
Louis, Missouri.
Kevin McEnery, MD, Assistant professor of radiology,
Division of Diagnostic Radiology, has accepted a position with M.D. Anderson
Cancer Center, Houston,
Texas.
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John Moyers, MD, assistant
in radiology, completed one
year of training in nuclear
medicine and has entered private practice in Nashville,
Tennessee.
Sean Muldowney, MD,
instructor in radiology and
cochief resident, Division of
Diagnostic Radiology, 19941995, completed four years of
training in diagnostic radiology and a one-year fellowship
in vascular and interventional
radiology. He has accepted a
position with Mori, Bean &
Brooks, PA, Jacksonville,
Florida
Theodore Passe, MD, assistant in radiology, completed
one year of training in diagnostic radiology.
Charles Pringle, MD, assistant in radiology, completed
one year of training in nuclear
medicine and has accepted a
position with Radiological
Group, PA, Jackson,
Mississippi.
Valerie Reichert, MD,
instructor in radiology, completed a four-year diagnostic
radiology residency and a
one-year fellowship in
abdominal radiology. She has
accepted a position with St.
Luke's Hospital, Chesterfield,
Missouri.

Michael Roarke, MD, assistant in radiology, completed
a four-year diagnostic radiology residency and one year
of training in nuclear medicine. He has accepted a position with Lyndon B. Johnson
General Hospital, University
of Texas, Houston.
Francis Schlueter, MD,
instructor in radiology, completed a four-year diagnostic
radiology residency and a
one-year fellowship in vascular and interventional radiology. He has accepted a
position with Good Samaritan Hospital, Cincinnati,
Ohio.
Ken Schreibman, MD,
PhD, instructor in radiology,
completed a one-year fellowship in musculoskeletal radiology and has accepted a
position with the University
of Mississippi Medical Center, Jackson.
Gregg Schubach, MD,
assistant in radiology, completed one year of training in
nuclear medicine and has
accepted a position with
Progressive Physician Associates, Easton, Pennsylvania.
Sharon Schubach, MD,
instructor in radiology, completed a one-year fellowship
in breast imaging.
Kurt Simpson, MD,
instructor in radiology, completed four years of training
in diagnostic radiology and a
one-year fellowship in vascular and interventional radiology. He has accepted a
position with the University
of Wisconsin, Clinical Science Center,Madison.

Isabel Soroeta, MD,
instructor in radiology, completed a one-year fellowship
in breast imaging and has
accepted a positionwith
Barnes-Jewish West County
Hospital, Creve Coeur, Missouri.
Jeffrey Spaeder, MD,
assistant in radiology, completed one year of training in
diagnostic radiology and has
entered the internal medicine residency program at
Johns Hopkins Hospital, Baltimore, Maryland.
Glenn Strome, MD,
instructor in radiology, completed a one-year fellowship
in musculoskeletal radiology
and has accepted a position
with Erlanger Memorial
Medical Center, Chattanooga, Tennessee.
Avinash Sud, MD, instructor in radiology, completed a
two-year fellowship in neuroradiology and accepted a
position with St. Jude Radiology medical Group, Inc.,
Fullerton, California.
Robert Swanson, MD,
assistant in radiology, completed four years of residency in radiation oncology,
and has accepted a position
with United States Air Force
Medical Center, Biloxi,
Mississippi.
Alexander Tsiaras, visiting
research associate, Division
of Radiological Sciences.
Michael Wallace, MD,
instructor in radiology, completed a one-year fellowship
in vascular and interventional radiology and has
accepted a position with the
University of Texas Southwestern Medical School,
Dallas.

23

wmmmmmmmmmmmmMmmmmMmmmmMmmmmMamiimmmmmmmmmmmm

1

FYI
THE DIRECTOR'S
OFFICE REPORT

APPOINTMENTS/
ELECTIONS

Continued from page 23

Jeffrey Brown, MD, associate professor of radiology,
was appointed to the Roster
of Distinguished Scientific
Advisors for the Radiological
Society of North America's
Research and Education
Fund.

Eric Weidman, MD, assistant in radiology and chief
resident, Division of Diagnostic Radiology, 1995-1996,
completed a four-year diagnostic radiology residency
and has accepted a position
with the David Grant Medical Center at Travis Air
Force Base, Fairfield,
California.
Pamela Woodard, MD,
instructor in radiology, completed a one-year fellowship
in chest radiology and has
accepted a position with
Mallinckrodt Institute of
Radiology.
Neda Yagan, MD, assistant
in radiology, completed a
four-year diagnostic radiology residency and has
accepted a positionwith the
University of Pittsburgh
Medical Center, Pittsburgh,
Pennsylvania.
Tongzeng Yang, PhD,
instructor in radiology, Division of Radiological
Sciences.

Terry Yeager, MD, instructor in radiology, completed a
one-year fellowship in vascular and interventional radiology and has accepted a
position with Tripler Army
Medical Center, Honolulu,
Hawaii.
Anthony Zelazny, MD,
assistant in radiology, completed four years of training
in diagnostic radiology and
has received a musculoskeletal fellowship at the University of Wisconsin Hospital
and Clinics, Madison.
Tinko Zlatev, MD, assistant
in radiology, completed four
years of training in diagnostic radiology and has
accepted a position with
Haywood County Hospital,
Clyde, North Carolina.

Louis Gilula, MD, professor
of radiology and director of
musculoskeletal radiology,
was elected as membership
chairman for the American
Society for Musculoskeletal
Radiology. He was
appointed as examiner for
the Musculoskeletal Section
of the Diagnostic Radiology
Oral Boards, Louisville, Kentucky, June 9-12.
Lawrence Kotner, MD,
associate professor of radiology, was appointed to a oneyear term as a medical staff
representative to the Medical
Executive Committee of
Barnes-Jewish Hospital.
Daniel Low, PhD, assistant
professor of radiology, was
appointed to a two-year term
on the Board of Representatives for the Missouri River
Valley Chapter of the American Association of Physicists
in Medicine.
Jeff Michalski, MD, assistant professor of radiology,
and Barry Siegel, MD, professor of radiology and
director of the Division of
Nuclear Medicine, were
appointed cochairmen of the
Protocol Review and Monitoring Committee of the
Washington University Cancer Center.
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Tom Miller, MD, PhD, was
elected as a member of the
House of Delegates of the
Society of Nuclear Medicine.
Scott Mirowitz, MD, associate professor of radiology,
co director of body MRI, and
chief of radiology at BarnesJewish Hospital - North Campus, was appointed editor of
Magnetic Resonance Imaging Clinics of North
America.
Douglas Robertson, MD,
PhD, assistant professor of
radiology and of orthopedic
surgery, was appointed to
the Public Affairs Committee
of the St. Louis Regional
Commerce and Growth
Association.
Joseph Roti Roti, PhD,
professor of radiology, associate director of the Radiation Oncology Center, and
chief of cancer biology, was
appointed to the State of
Nebraska Department of
Health's Technical Review
Panel for the Cancer and
Smoking Disease Research
Program. He also was
appointed as a reviewer for
the IEEE Standards Coordinating Committee 28, Subcommittee 4, In vitro
Literature Review Working
Group.
Peter Shile, MD, PhD,
assistant professor of radiol
ogy, was appointed as a clin
ical reviewer for the
American College of Radiology Stereotactic Breast
Biopsy Accreditation Program. He also was
appointed to a three-year
term on the American Roenl
gen Ray Society Scientific
Program Committee for
Breast Imaging.
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Barry Siegel, MD, professor
of radiology and director of
the Division of Nuclear Medicine, was appointed by the
United States Pharmacopeia
Division of Information
Development to a five-year
term on the Radiopharmaceuticals Expert Advisory Panel.
The multidisciplinary panel
will develop and approve
drug and therapeutics information and contribute to any
decisions relating to
radiopharmaceuticals.

MIR Education Center
Joe Quennoz, Dave Smugala, and David Piper of the MIR
plant facilities team are renovating space on the fourth
floor of the Old Children's Annex in preparation for the
Education Center's move from the Institute's 10th floor.

Marilyn Siegel, MD, professor of radiology, was
appointed to a three-year term
as a member of the Convention Program Committee of
the American Institute of
Ultrasound Medicine.
Celette Skinner, PhD, assistant professor of radiology,
was appointed as a member of
the Prevention and Control
and Human Cancer Genetics
Research Programs, Washington University Cancer Center.
Clark West, MD, assistant
professor of radiology and
director of emergency and
trauma radiology, was
appointed to a one-year term
as chairman of the Membership Committee for the American Society of Emergency
Radiology.
Jeffrey Williamson, PhD,
professor of radiology and
chief of brachytherapy
physics, was elected as a fellow of the American Associaion of Physicists in Medicine,
le was appointed to the U.S.
Nuclear Regulatory Commission Advisory Committee on
ledical Use of Isotopes.
Franz Wippold, MD, associate professor of radiology,
was appointed as guest invesigator for the Armed Forces
stitute of Pathology's study
on spinal cord tumors.
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FELLOWSHIPS/
GRANTS
Thomas Conturo, MD,
PhD, assistant professor of
radiology, as principal investigator, received a $300,000
grant from the McDonnell
Center for Higher Brain
Function Major Grants
Program for his research on
"Functional neuronal imaging with magnetic resonance
in humans and primates."
Coinvestigators on the threeyear grant are Marcus
Raichle, MD, codirector of
the Division of Radiological
Sciences; Avi Snyder, PhD,
MD, Department of Neurology; Robert McKinstry,
MD, PhD, assistant in radiol-

ogy; Harold Burton, PhD,
Department of Anatomy and
Neurobiology; Tongzeng
Yang, PhD, instructor in
radiology; and Erbil Akbudak, PhD, graduate research
assistant in radiology.
Duffy Cutler, PhD, assistant professor of radiology,
received a three-year grant
in the amoutn of $524,998 for
research on "Radiation
dosimetry of Cu-64-labeled
radiotherapy agents using
positron emission
tomography."

Mokhtar Gado, MD, professor of radiology, received
a five-year grant grant from
the National Institutes of
Health for research on magnetic resonance imaging of
the structural brain changes
associated with cognitive
changes due to cerebrovascular disease.
Marshall Hicks, MD, associate professor of radiology,
received a Seed Grant Award
from the Radiological Society of North America's
Research and Education
Fund. The one-year grant
will support research in
"Interventional and vascular
techniques for hepatic gene
therapy."
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FELLOWSHIPS/
GRANTS
Continued from page 25
Weili Lin, PhD, assistant
professor of radiology,
received a four-year grant in
the amount of $791,233 from
the National Institute of
Neurological Disorders and
Stroke for research on "Tissue water measurements of
brain edema with MRI."
Daniel Low, PhD, assistant
professor of radiology,
received the 1996 American
Association of Physicists in
Medicine Travel Award, presented at the AAPM's annual
meeting in July in Philadelphia. The award will support Low's travels to Great
Britain, where he will present invited lectures at several universities.
Gary Luker, MD, instructor
in radiology, received a oneyear RSNA Fellowship supported by Mallinckrodt
Medical Inc. from the Radiological Society of North
America's Research and
Education Fund. The
$30,000 grant was awarded
for Luker's research in
"Characterization of Tc99mN2O2P2 complexes for functional imaging of multidrug
resistance in cancer." For
this same research, Luker
also received a one-year,
$30,000 grant from the Society of Nuclear Medicine.
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Douglas Robertson, MD,
PhD, assistant professor of
radiology and of orthopedic
surgery, received a threeyear Whitaker Foundation
Biomedical Research Grant
in the amount of $210,000
for research on "Modeling
and analysis of acetabular
defects caused by failed hip
prostheses."
Celette Skinner, PhD,
assistant professor of radiology, as principal investigator, received a $20,000
one-year grant from the
Barnard Hospital Board for
research on "Beliefs about
breast cancer, risk factors
and personal risk, and preferences regarding risk counseling among low-income
African-American women in
urban St. Louis."
Ge Wang, PhD, assistant
professor of radiology,
received a $543,628 five-year
grant from the National
Institute of Diabetes and
Digestive and Kidney Diseases for the research project "Unraveling the GI Tract
by Spiral CT." Michael
Vannier, MD, professor of
radiology and chief of the
image processing lab, is
coinvestigator.

Michael Vannier, MD, professor of radiology and chief
of the image processing lab,
received a $1,251,152 grant
from the National Institute
of Neurological Disorders
and Stroke. The five-year
grant will fund the research
project "Normal MR neuromorphometry by global pattern matching."
Jeffrey Williamson, PhD,
professor of radiology and
chief of brachytherapy
physics, received a threeyear grant from the National
Cancer Institute for
"Brachytherapy dosimetry
using plastic scintillator."
Coinvestigators for the
$752,000 grant are Robert
Binns, PhD, Washington University Department of
Physics; Assen Kirov, MS;
John Wong, PhD, William
Beaumont Hospital, Royal
Oaks, Michigan; and Charles
Hurlbut, Epikon, Inc., Bedford Heights, Ohio.
Pamela Woodard, MD,
instructor in radiology,
received the 1996 Siemens
Medical Systems/RSNA Fellowship from the Radiological Society of North
America's Research and
Education Fund. The oneyear $30,000 fellowship will
support her research project
"Identification of proximal
coronary artery stenosis
with 3D MR retrospective
respiratory gating."
Woodard also received an
American Heart Association
Fellows Grant for her
research in coronary magnetic resonance
angiography.

HONORS/
AWARDS
Carolyn Anderson, PhD,
assistant professor of radiology, was an invited instructor at the Summer School in
Nuclear Chemistry, a
Department of Energy-sponsored program for undergraduates in chemistry, at
San Jose State University,
San Jose, California, July 8 12.
Ty Bae, MD, PhD, assistant
in radiology, received a
$25,000 Research Resident
Award from the Radiological
Society of North America's
Research and Education
Fund. The one-year award
will support Bae's research
project "Optimization of
contrast enhancement during spiral CT: effect of alterations in cardiovascular
physiology."
Evren Senol, graduate
research assistant, received
first prize in the Washington
University Research Fair,
sponsored by the Association of Graduate Engineering Students.
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Symposium, Institute of
Radiological Science, Mater
Hospital, Dublin, Ireland,
April 15.

)iagnostic
Radiology

Bahman Emami, MD, professor of radiology, spoke on
"RTOG protocol 93-11/threedimensional conformal radiotherapy of lung cancer:
rationale for new dose escalation study schema" at the
IASLC Workshop - Controversies in Staging and Combined Treatment Modalities
in Lung Cancer, Bruges, Belgium, June 23 - 27. Represented "Squamous cell
carcinoma of the floor of
mouth: evaluation of longterm results and prognostic
factors" and "Squamous cell
carcinoma of the oral tongue:
evauation of long-term
results and prognostic factors" at the 4th International
Conference on head and
Neck Cancer, Toronto,
Ontario, Canada.

Donald Heck, MD, and Thomas
Vaughan, MD, (seated) are the diagnostic radiology chief residents for
1996-1997. Heck received a medical degree from Duke University;
Vaughan is an alumnus of Washington University School of Medicine.

LECTURES/
PRESENTATIONS
Carolyn Anderson, PhD,
assistant professor of radiology, presented "Preclinical
internal emitter therapy studies with Cu-64 and Cu-67
labeled antibodies and peptides" at the Los Alamos
National Laboratory, Los
Jamos, New Mexico, June 7.
larold Bennett, MD, PhD,
ssistant professor of radiology, presented "Role of radiology in detection and
staging of colorectal cancer"
at the 8th Annual American
Dancer Society Program on
3reast and Colorectal Can-
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cer, Memorial Hospital of
Carbondale, Illinois, April 27.

Medicine, Philadelphia,
Pennsylvania, July 23.

James Blaine, DSc, professor of radiology and chief of
the electronic radiology lab,
presented a tutorial, "Selecting networks for health data
and images," at the American
Medical Informatics Association's 1996 Spring Congress,
Kansas City, Missouri,
June 5 - 8.

James Brink, MD, associate
professor of radiology and
codirector of computed body
tomography, presented "Spiral CT angiography" and
"Contrast media physiology:
emphasis on hepatic imaging" at the Siemens CT Users'
Meeting, Scottsdale, Arizona,
June 7 and 8.

Walter Bosch, DSc, instructor in radiology, spoke on
"Data management for 3D
CRT" at the 38th Annual
Meeting of the American
Association of Physicists in

Farrokh Dehdashti, MD,
assistant professor of radiology, presented "Breast imaging with PET" and "Epilepsy
imaging with PET" at the
Feasibility of PET Imaging

Keith Fischer, MD, associate professor of radiology,
spoke on "Scintigraphic
markers of outcome after
lung volume reduction
surgery as assessed with preoperative lung scans" at the
American Roentgen Ray
Society 96th Annual Meeting,
San Diego, California, May 5 10.
David Gierada, MD,
instructor in radiology, presented "Dynamic MR imaging
to analyze respiratory
mechanics in patients having
lung volume reduction
surgery," which received a
Certificate of Merit Award;
"Atelectatic pseudomass in
severe bullous emphysema,"
and "Dynamic MR imaging of
respiratory coordination
before and after lung volume
reduction surgery" to the
American Roentgen Ray
Society 96th Annual Meeting,
San Diego, California,
May 5 -10.
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LECTURES/
PRESENTATIONS
continued from page 27
Louis (iilula, MD, professor of radiology and chief of
musculoskeletal radiology,
lectured on "Imaging
approach to wrist pain" at
The 86th Congress of the
Central Japan Association of
Orthopaedic Surgery and
Traumatology, Nara, Japan,
May 30 and 31. As visiting
professor, he spoke on
"Plain film approach to musculoskeletal tumors" and
"Radiographic interpretation
of ligament instabilities of
the wrist" at the Fukuoka
University School of Medicine, Fukuoka, Japan, June
3. Gilula lectured on
"Arthrography and CT
arthrography," "Roentgenographic approach to hand
and wrist pain," "Percutaneous bone biopsy," and
"MRI of wrist and hand" at
the Advance Course in Musculoskeletal Radiology,
Margherita di Savoia, Italy,
June 21-23.
Harvey Glazer, MD, professor of radiology, presented
the instructional course "Pitfalls in the radiological diagnosis of bronchogenic
carcinoma" at the American
Roentgen Ray Society 96th
Annual Meeting, San Diego,
California, May 5 -10.
Mary Graham, MD, assistant professor of radiology,
spoke on "Multimodality
treatment of esophagus cancer," "Radiation therapy for
lung cancer," and "New technology in radiation therapy maximize the potential" at
the Southern California ACS
Traveling Oncologist Lecture
Series, Los Angeles, California, June 3 - 7.
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Jay Heiken, MD, professor
of radiology and chief of
abdominal radiology, presented "Colorectal carcinoma: detection, staging,
and follow-up," "CT and MRI
evaluation of gynecologic
neoplasms," and "Testicular
germ cell neoplasms: detection, staging, and follow-up"
to the Annual Meeting of the
Oklahoma State Radiological
Society, Oklahoma City,
Oklahoma, April 12 and 13.
He presented "Diffuse Diseases of the Liver" at the Categorical Course on Radiology
of the Liver, Biliary Tract,
and Pancreas, at the American Roentgen Ray Society
96th Annual Meeting, San
Diego, California, May 5 -10.
Eric Klein, MS, assistant
professor of radiology,
spoke on "Clinical uses of
multileaf collimation and
enhanced dynamic wedge" at
the Varian Applications
meeting, Williamsburg, Virginia, June 21.
Weili Lin, PhD, assistant
professor of radiology, lee- ■
tured on "Contrast-enhanced
magnetic resonance angiography of carotid artery wall
in pigs" and "Simultaneous
and quantitative separation
of Rl and R2 change in vivo
fMRI using single-shot Gp2"
at the ISMRM meeting, New
York City, New York, April
29 and May 1.
Daniel Low, PhD, assistant
professor of radiology, presented "Use of physical modulators for intensity

modulated radiation therapy" at the American Association of Physicists in
Medicine Annual Meeting,
Philadelphia, Pennsylvania,
July 21-25.
Elizabeth McFarland, MD,
assistant professor of radiology, presented "Imaging of
focal liver lesions" at the
Barnes-Jewish Hospital Medical Grand Rounds, St. Louis,
Missouri, May 19.
Robert McKinstry, MD,
PhD, assistant in radiology,
presented "Echo planar
human diffusion tensor
imaging with tetrahedral
encoding" and a poster
exhibit, "Quantitative measurements of brain water
apparent diffusion coefficient in healthy full-term
neonates," to the 4th Annual
Meeting of the Internationational Society for Magnetic
Resonance in Medicine, New
York City, April 28 - May 3.
Eduardo Moros, PhD,
assistant professor of radiology, spoke on "Lateral conformability and penetration
depth controllability using
ultrasound arrays and reflectors" at the 1996 Surgical
Application of Energy
Sources Conference, Estes
Park, Colorado, May 17 -19.
He presented "Power deposition conformability of the
SURLAS: a system for external simultaneous thermoradiotherapy" to the 7th
International Congress on
Hyperthermic Oncology
Meeting, Rome, Italy, April 9
-13. Moros presented "The
radial transmission line as a
broad-band shielded exposure system for microwave
irradiation of large numbers
of culture flasks" to the 18th
Annual Meeting of the Bioelectromagnetics Society
(BEMS), Victoria, British
Columbia, Canada, June 9 14.

Douglas Robertson, MD,
PhD, assistant professor of
radiology and of orthopedic
surgery, spoke on
"Advanced technologies
applied to orthopedic joint
replacement" at the St. Louis
Regional Commerce and
Growth Association, St.
Louis, Missouri, May 17.
Joseph Roti Roti, PhD,
professor of radiology, associate director of the Radiation Oncology Center, and
chief of cancer biology, presented "Consideration of the
use of the alkaline comet
assay for routine screen of
DNA damage, "Further evidence that S-phase progression is required for
hyperthermia-induced cell
death in Hela cells,"
"Chronic thermotolerance
with continued cell proliferation," "Enhanced turnover
rate of topoisomerase 113
mRNA by agents known to
induce G2-delay," and "Differential radioprotection of
oncogene transfected rat
embryo ceUs by WR1065
correlates with DNA supercoiling changes" to the 44th
Annual Meeting of the Radi
ation Research Society,
Chicago, Illinois, April 14 17. As invited speaker, he
lectured on "Nuclear matrc
mediated DNA organizatior
and the radioresistance/sersitivity of transformed cells'
at the 21st Annual Meeting
of the Gilbert H. Fletcher
Society, Williamsburg, Virginia, April 18 - 20. Roti Ro
spoke on "Measurement of
DNA damage by the alkalint
comet assay after in vitro
exposure to 835 Mhz electri
magnetic radiation," "Lack
of any significant effects of
835 Mhz FM or CDMA
microwave exposure upon
macromolecular synthesis
rates, cell growth, or cell
cycle phase distribution,"
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"Comparison of stereotactic
and template injection of
«ethods to implant 9L
loma cells in the rat brain,"
and "Further characterization and modification of a
chemically induced rat brain
tumor model for tumor promotion studies" at the 18th
Annual Meeting of the Bioelectromagnetics Society,
r
ictoria, British Columbia,
lanada, June 9 -14.
Henry Royal, MD, professor of radiology and associ(te director of the Division
f Nuclear Medicine, presented "SNM procedure
guidelines" to the Mid-eastern Society of Nuclear Medicine Chapter, Rockville,
Maryland, April 13. He presented the keynote
address, "Technology assessment: the good, the bad, and
the horrific," as well as "Measuring value: David Jones or
target" and "Pulmonary
embolism: Technology
assessment gone mad!" to
the Australian and New
Zealand Society of Nuclear
Medicine, Ayer's Rock, Australia, June 28 - 30.

Marilyn Siegel, MD, professor of radiology, spoke on
"Problems and pitfalls in
pediatric MRI" and "Pediatric musculoskeletal MRI"
at the 19th Annual Course of
the Society of Computed
Body Tomography and Magnetic Resonance, Scottsdale,
Arizona, May 18 - 20. As
invited lecturer, she presented "Recent advances in
pediatric ultrasound" to the
Korean Society of Medical
Ultrasound, Seoul, Korea,
May 11. As visiting professor, Siegel spoke on "Applications of duplex and
colored Doppler sonography
in the pediatric abdomen"
and "Duplex and color
Doppler Sonography of the
neonatal brain" at the Seoul
National University Children's Hospital, Seoul,
Korea, May 13 and 14. She
chaired a special focus sesson on ultrasonography and
spoke on "Doppler ultrasonigraphy in the acute pediatric abdomen" and "Breast
sonography in children" at
the International Pediatric
Radiology Meeting, Boston,
Massachusetts, May 25 - 29.

Stuart Sagel, MD, professor of radiology and chief of
chest radiology, spoke on
'■ "CT of the pleura" and "Role
of CT and MRI in staging
bronchogenic carcinoma" at
the Annual Conference on
Chest Disease of the Fleischner Society, Vancouver,
British Columbia, Canada,
June 13 -15.

Celette Skinner, PhD,
assistant professor of radiology, as a panel member, presented "What we know
about the effectiveness of
tailoring" at the initial meeting of the National Cancer
Institute's panel on "Tailored
Messages in Cancer Communications", Bethesda, Maryland, July 17.

Jarry Siegel, MD, professor of radiology and director
Df the Division of Nuclear
fedicine, presented
"Somatostatin-receptor
tiaging of neuroendocrine
lors" to the Catholic University Graduate School,
Seoul, Korea, May 13.

Richard Slone, MD, assistant professor of radiology,
presented "Radiologic
assessment of structural features in emphysema" and
"Comparison of radiologic
features with clinical data
and outcome following lung
volume reduction surgery" at
the Multidisciplinary Volume
Reduction Research Meeting, St. Louis, Missouri, April
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23. He presented "Preoperative radiologic evaluation
and patient selection criterion for lung volume reduction surgery," "Common
pitfalls leading to rejection
of major papers submitted to
AIR," and "Preoperative
radiologic findings in
patients with an unfavorable
outcome after lung volume
reduction surgery" at the
American Roentgen Ray
Society 96th Annual Meeting, San Diego, California,
May 5 -10.
Douglas Spitz, PhD, assistant professor of radiology,
as guest lecturer, spoke on
"Mechanisms of resistance
to oxidative stress" at the St.
Louis University Health Sciences Center, St. Louis, Missouri, April 12. He
presented "The cytotoxicity
of anticancer agents in
H202-resistant hamster
fibroblasts," "Mechanisms of
heat resistance in oxidative
stress resistant cells," and
"Nitric oxide induced resistance to oxidative stress" to
the 44th Annual Meeting of
the Radiation Research Society, Chicago, Illinois, April
14 -17. Spitz presented
"Does 835 MHz FMCW irradiation alter nitric oxide production by the J774.16
mouse macrophage of cell
line?", "Comparison of
stereotactic and template
injection methods to implant
9L glioma cells in the rat
brain," and "Further characterization and modification
of a chemically induced rat
brain tumor model for tumor
promotion studies" to the
18th Annual Meeting of the
Bioelectromagnetics Society, Victoria, British Columbia, Canada, June 9 -14.

Alfred Tinger, MD, assistant in radiology and chief
resident, Radiation Oncology Center, spoke on
"Patient motion within an
immobilization device" at
the 4th International Conference on Electronic Portal
Imaging, Amsterdam, The
Netherlands, June 10.
Jeffrey Williamson, PhD,
professor of radiology and
chief of brachytherapy
physics, as invited speaker,
presented the refresher
course "Brachytherapy
source strength, quantities,
and calibrations" at the 38th
Annual American Association of Physicists in Medicine, Philadelphia,
Pennsylvania, July 21-25.
Franz Wippold, MD, associate professor of radiology,
as visiting professor, spoke
on "Head and neck imaging
update" at the National
Naval Medical Center,
Bethesda, Maryland; Walter
Reed Army Medical Center,
Washington, DC; and Uniformed Services University
of the Health Services,
Bethesda, Maryland, April
29 - May 10.
Pamela Woodard, MD,
instructor in radiology, as
invited lecturer, spoke on
"Cardiac and thoracic vascular imaging: recent developments in MR and spiral CT"
at the St. Louis University
Health Sciences Center, St.
Louis, Missouri, April 10.
She presented "Identification of coronary artery
stenoses with 3D MR retrospctive respiratory gating" to
the American Roentgen Ray
Society 96th Annual Meeting, San Diego, California,
May 5 -10.
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SYMPOSIA

Robert Gropler, MD,
comoderator, "Cardiovascular-PET: myocardial
perfusion."

SOCIETY OF NUCLEAR
MEDICINE

David Piwnica-Worms,
MD, PhD, comoderator,
"Radiopharmaceutical chemistry: preclinical studies II."

The 43rd Annual Meeting
Denver, Colorado
June 3 - 5, 1996
Farrokh Dehdashti, MD,
as first author, received the
1996 Outstanding Manuscript Award for one of the
five best papers published in
the Journal of Nuclear Medicine. The paper, "Positron
tomographic assessment of
estrogen receptors in breast
cancer: comparison with
FDG-PET and in vitro receptor assays," was coauthored
with Barry Siegel, MD;
Duffy Cutler, PhD;
Michael Welch, PhD;
Thomas Bonasera, MA;
Maureen Fusselman, MS,
BSN; and Diane Detert,
CNMT, of Mallinckrodt
Institute; Joanne Mortimer,
MD, of Washington University's Division of Medical
Oncology; Landis Griffeth,
MD, PhD, of Baylor University Medical Center, Waco,
Texas; and John Katzenellenbogen, PhD, of the University of Illinois, Urbana.

SCIENTIFIC PAPERS
Carolyn Anderson, PhD,
moderator, "Radiopharmaceutical chemistry: therapeutic and other nuclides I."
Duffy Cutler, PhD, comoderator, "Instrumentation and
data analysis: three-dimensional PET."
Farrokh Dehdashti, MD,
moderator, "Oncology diagnosis (nonantibody): breast
cancer newer tracers."
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Barry Siegel, MD, moderator, "Radiobiology I dosimetry."
Carolyn Anderson, PhD;
Judith Connett, PhD*; Carl
Germain, MS*; Li Guo, MS*;
Buck Rogers, PhD**; Sally
Schwarz, RPh, MS; Alan
Fritzberg, PhD***; Michael
Welch, PhD, "Cu-64-Labeled
BAT-21T-NR-LU-10 Fab: an
agent for PET imaging and
radioimmunotherapy."
*Washington University, St.
Louis, Missouri. ^University of Alabama, Birmingham. ***NeoRx
Corporation, Seattle,
Washington.
Carolyn Anderson, PhD;
Elizabeth Sherman, BA;
Deborah McCarthy, PhD;
Laura Bass, PhD; Lynne
Jones, BA; Michael
Cristel, MA; Margaret
Lanahan, MS; Ruth Shefer,
PhD*; Robert Klinkowstein,
PhD*; Michael Welch, PhD,
"Radiotherapy studies of Cu64-labeled teta-octreotide in
Tumor-bearing rats." *Newton Scientific Inc., Winchester, Massachusetts.
Judith Connett, PhD*; Carolyn Anderson, PhD; Li
Guo, MS*; Sally Schwarz,
RPh, MS; Carl Germain,
MS*: Gordon Philpott, MD*;
Michael Welch, PhD,
"Long-term radioimmunotherapy studies of Cu64 anti-colon carcinoma
monoclonal antibody (MAb)1A3, intact and F(ab')2 singly
and in combination in the
GW39-hamster model."

*Washington University
School of Medicine, St.
Louis, Missouri.
Duffy Cutler, PhD; Farrokh Dehdashti, MD;
Barry Siegel, MD; Joanna
Downer, MS; Michael
Welch, PhD, "Investigation
of a prostate ligand 16£-[F18]Fluoro-59-Dihydro-testosterone for staging of
prostate carcinoma."
Fidelma Flanagan, MD;
Farrokh Dehdashti, MD;
Joanne Mortimer, MD*;
Barry Siegel, MD;
Stephanie Jonson, MS;
Michael Welch, PhD, "PET
assessment of response to
tamoxifen therapy in
patients with metastatic
breast cancer." *Washington
University, St. Louis, Missouri.
Fidelma Flanagan, MD;
Farrokh Dehdashti, MD:
Barry Siegel, MD: Diana
Trask, RN; Sudhir Sundaresan, MD*; Alexander Patterson, MD*; Joel Cooper,
MD*,"Staging of esophageal
cancer with FDG-PET."
*Washington University, St.
Louis, Missouri.
Fidelma Flanagan, MD;
Farrokh Dehdashti, MD;
Olagunji Ogunbiyi, MD;
Barry Siegel, MD; Diana
Trask, RN; Elisa Birnbaum,
MD*; James Fleshman, MD*;
Ira Kodner, MD*, "The role
of FDG-PET in advanced
primary and recurrent colorectal cancer." *Washington University, St. Louis,
Missouri.
Robert Hancock, PhD*;
Michael Welch, PhD;
David Reichert, PhD,
"Molecular mechanics investigation of Tc(V) complexes." *IBC Advanced
Technologies, American
Fork, Utah.

Pilar Herrero, MD*; Judy
Hartman, research patient
coordinator*; Robert Gropler, MD; Steven Bergmann,
MD*, "Quantification of
myocardial perfusion with
PET using carbon-11 acetate
and a compartmental model
in human subjects." *Washington University, St. Louis,
Missouri.
Teresa Jones-Wilson,
PhD; Kim Deal, PhD; Deborah McCarthy, PhD;
David Reichert, PhD; Carolyn Anderson, PhD;
Michael Welch, PhD, "The
effect of charge on the retention of Copper-64 radiopharmaceuticals in the clearance
organs."
Hans Lee, MD*; Hiie Gussak,
ultrasound technician*;
Victor Davila-Roman, MD*;
Deborah Delano, RN;
Patricia Rubin, MD*; Robert
Gropler, MD, "Contractile
reserve is not dependent
solely upon changes in
myocardial blood flow."
'"Washington University,
St. Louis, Missouri.
Deborah McCarthy, PhD;
Ruth Shefer, PhD*; Robert
Klinkowstein, PhD*; Laura
Bass, PhD; William Margtneau, cyclotron supervisor; Carolyn Anderson,
PhD; Michael Welch, PhD
"The efficient production oi
high specific activity Coppe 64 using a biomedical
cyclotron." *Newton Scientific Inc., Winchester,
Massachusetts.
Eyal Mishani, PhD;
Michael Cristel, MS; Timothy McCarthy, PhD;
Michael Welch, PhD,
"Radiosynthesis binding
affinity and biodistribution
of 3-[F-18]fluoro-N-(3,a,3-trifluoro-m-toly)piperazine
(FTFMPP), a Radioligand fc
the Serotonin System."
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Vijay Sharma, PhD; S. Wey,
PhD*; Laura Bass, PhD;
Carolyn Crankshaw, MS;
Mark Green, PhD*; Michael
Welch, PhD; David
Piwnica-Worms, MD, PhD;
"Monocationic N402 schiffbase phenolate complexes of
Ga(III): novel PET imaging
agents of the human multidrug resistance (MDR1) Pglycoprotein." *Purdue
University, West Lafayette,
Indiana.
ijay Sharma, PhD; Vallabaneni Rao, PhD; David
Reichert, PhD; Carolyn
Crankshaw, MS; Michael
Welch, PhD; David
Piwnica-Worms, MD, PhD,
"Effects of the central coordination metal on recognition of ethylenediamineN-N'-Bis[Propyl (R-Benzylimino)] metal (III) cations by
the multidrug resistance
(MDR1) P-glycoprotein."
Jerold Wallis, MD; Tom
Miller, MD, PhD; Mihelle
Miller,* James Hamill, PhD**,

"Rapid 3-D projection in iterative reconstruction using
gaussian diffusion." *summer student **Siemens Medical Systems, Hoffman
Estates, Illinois.
Samuel Wang, MD; Keith
Fischer, MD; Richard
Slone, MD; David Gierada,
MD; Roger Yusen, MD*; Joel
Cooper, MD*, "Ventilation
perfusion scintigraphy in the
evaluation of patients for
lung volume reduction
surgery." * Washington University School of Medicine,
St. Louis, Missouri.
Jian Zhang, MS; Ming Xu,
MS; Elizabeth Sherman,
BA; Carmen Dence, MS;
Timothy McCarthy, PhD;
Michael Welch, PhD, " In
vivo evaluation and PET
study of a C-ll labeled neuronal nitric oxide synthase
(nNOS) inhibitor S-Methyl-LThiocitrulline ([C-ll]
MTICU)."

POSTER SESSIONS
Tom Miller, MD, PhD,
moderator, "Instrumentation
and data analysis: image
generation and analysis."
Laura Bass, PhD; James
Duncan, MD, PhD; Mary
Stephenson, medical
research technician;
Michael Cristel, MS; Carolyn Anderson, PhD, "In
vivo metabolism of IN-111DTPA-Octreotide."
Carolyn Cranskshaw, MS;
David Piwnica-Worms,
MD, PhD, "TC-99m-SESTAMIBI may be a transport
substrate of the human multidrug resistance-associated
protein (MRP)."
James Duncan, MD, PhD;
Mary Stephenson, medical
research technician; Carolyn Anderson, PhD; Herman Wu, medical student*,
"IN-111-DTPA octreotide and
other polypeptides are delivered to lysosomes in the
liver, kidneys, and target tissues." *Washington University, St. Louis, Missouri.

Pilar Herrero, MD*; Robert
Gropler, MD; Mark Shelton,
MD*; Steven Bergmann, MD,
PhD*, "Use of compartmental
models of Carbon-11 acetate
to measure myocardial oxygen consumption: validation
in human subjects." ♦Washington University, St. Louis,
Missouri.
John Ollinger, DSc*; William
Powers, MD; Lennis Lich,
technical supervisor,
"Shielding to reject scatter
from outside the field-of-view
in infant PET scans." ♦Washington University, St. Louis,
Missouri.
Patricia Rubin, MD*; Deborah Delano, RN; Jason
Rogers, MD*; Robert Gropler, MD, "Cardiac PET with
C-ll acetate identifies
patients referred for cardiac
transplant who benefit from
high-risk coronary bypass
surgery." *Washington University, St. Louis, Missouri.
Jerold Wallis, MD; Tom
Miller, MD, PhD, "Use of
iterative methods in reconstruction of 180° data."

Residents, trainees, and fellows (or 1995-1996 were (front row, left to right) Doctors Pamela Woodard; Rachel Gordon; Christine Menias; Myeong Yoon; Michele Semin;
Neda Yagan; Gilbert Jost, chief. Division of Diagnostic Radiology; Donald Heck; Eric Weidman; Ronald Evens, director of the Institute; Dennis Balfe, director of the Diagnostic
Radiology Program; Farrel VanWagenen; Thomas Vaughan; Mary Alderman; Isabel Soroeta; Sharon Schubach; Debra Lau; (second row) Michael Roarke; Samuel Wang;
lawrence Kaskowitz; John Felker; Sanjeev Bhalla; Joshua Shimony; Peter Salazar; Dallas Peck; Mitchell Miller; Gavin Slethaug; Perry Pickhardt; Michael Boerner; James Milburn; Gregg Schubach; Sean Pierce; John Carico; Sean Muldowney; (third row) Felix Song; David Hillier; Jonathon Gurney; David Kim; Scott Kaltman; Kim Baker; Stephanie
Hiskes; Kevin Berger; David Youmans; Sandy Ruhs; Kraig Kirkpatrick; Gregory Cizek; Anthony Zelazny; Donald Frei; (back row) George Brown; Kurt Simpson; Anthony Foti;
Jahn Butman; Richard Edelstein; Eric Maiden; Jeffrey Friedland; Steven Winn; Matthew Fleishman; Andrew Fisher; Rory Satterfield; Robert McKinstry; Daniel Hassell; John
Healy; Paul Guillerman; Robert Vogler; Glenn Hammer; Kenneth Ford; Michael Naylor; Ty Bae; Ken Schreibman.
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IN MEMORIAM

Michel M. Ter-Pogossian, PhD, an internationally known
pioneer in the use of cyclotron-produced radionuclides
in biomedical research, died suddenly of a heart attack on
June 19, 1996, while visiting in Paris. He was emeritus professor of radiology at Washington University's Mallinckrodt
Institute of Radiology. While the scientific world has lost an
innovatve researcher who fostered collaboration among scientists and clinicians from various disciplines in order to
achieve improved medical imaging, we at Mallinckrodt
Institute have lost a dear friend and colleague.
Born on April 21,1925, in
Berlin, Michel Ter-Pogossian
was the only child of Armenian parents who had settled
in Germany after escaping
ethnic persecution in their
homeland following World
War I. The family moved to
France when Michel was a
young child. His fascination
with science began as a
youngster and was fueled by
experiments involving his
toy physics and chemistry
kits. He later earned
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degrees in science from the
University of Paris and from
the Institute of Radium in
1943 and 1946, respectively.
It was in 1946 that TerPogossian came to the
United States to further his
education, an outgrowth of
his father's concern about
young Michel's involvement
with the war resistance
efforts in France.
Ter-Pogossian was
drawn to Washington University in large part by the
reputation of Arthur Holly

Compton, a physicist and a
Nobel laureate, who was the
university's chancellor. In
1946, while studying for his
degree, Ter-Pogossian
worked in the Department of
Physics as a research assistant. He received a master's
degree in 1948 and a doctoral degree in nuclear
physics in 1950. He joined
the faculty of Mallinckrodt
Institute in 1950 and was
appointed as professor of
radiation sciences in 1961.
He also held a joint appointment as professor of biophysics in physiology. In
1973, he was named head of
Mallinckrodt Institute's Division of Radiation Sciences,
but the self-professed
"research junkie" missed
devoting his full time to laboratory work. In 1990, he
stepped down from his
administrative duties to
return to his first love:
research.
Among his many
accomplishments, Michel
Ter-Pogossian will foremost
be remembered as the
"father of PET." In the early
1970s, he led a collaborative
research team of physical
scientists, chemists, and
physicians who developed
the concept of positron
emission tomography (PET).
A major medical contribution, PET displays actual
metabolic activity within different regions of organs and
tissues, thereby extending
scientists' and physicians'
understanding of basic biological processes and providing a basis for the
improved diagnosis of diseases. He played a major
role in developing the concept of short-lived isotopes

and in designing and constructing the first PET scanner as well as the first
multislice and the first timeof-flight PET scanners.
During a career that
spanned more than four
decades, he earned numerous accolades for his
achievements in nuclear science, including France's
Gold Medal Award of the
Societe Francaise de
Medecine Nucleaire et de
Biophysique, Canada's prestigious Gairdner Award, St.
Louis' Peter H. Raven Lifetime Award of the Academy
of Sciences, as well as the
Society of Nuclear Medicine's Georg Charles de
Hevesy Nuclear Medicine
Pioneer Award and the Paul
C. Aebersold Award. TerPogossian was a member of
many professional societies.
He was elected in 1987 to
the Institute of Medicine and
served on the editorial
boards of major scientific
journals, including the
American Journal of
Roentgenology, the Journal
of Nuclear Medicine, and
the Journal de Biophysiqve
& Medecine Nucleaire.
Dr. Ter-Pogossian was a
prolific author, with more
than 250 papers and book
chapters to his credit, and
was a charter member of t le
American Nuclear Society
and a fellow of the Americ in
Physical Society. In addition, he was a past trustee if
the Academy of Sciences o
St. Louis and served as an
advisor for several Department of Energy and Nation il
Institutes of Health
committees.
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1 Chancellor Mark Wrighton, Dr. Todd
Wasserman, and Christine Bowman, a former
patient of Dr. Wasserman's.
2 Quentin Ringenberg travelled from Naples,
Florida, to attend the celebration.
3 Mr. and Mrs. Harold Gilling
4 Norman Nachman, cancer-free for 22 years.
5 The Cancer Infomation Center was one of the
stops on the guided tours.
6 Anne and Sam Flora, both cancer survivors,
with daughter Elizabeth.
7 Bernadette Rondle (center, shown with family
members) spoke about her successful fight
against lymphoma.
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